Schonfeld Strategic Advisors’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.33M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $60.4K | Buy |
|
|||||
|
2024
Q4 | $78K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.53M | Buy |
|
|||||
|
2023
Q3 | $2.32M | Buy |
|
|||||
|
2023
Q2 | $2.34M | Sell |
|
|||||
|
2023
Q1 | $2.2M | Sell |
|
|||||
|
2022
Q4 | $2.37M | Buy |
|
|||||
|
2022
Q3 | $1.34M | Sell |
|
|||||
|
2022
Q2 | $1.88M | Sell |
|
|||||
|
2022
Q1 | $1.81M | Sell |
|
|||||
|
2021
Q4 | $2.1M | Sell |
|
|||||
|
2021
Q3 | $2.29M | Sell |
|
|||||
|
2021
Q2 | $2.22M | Buy |
|
|||||
|
2021
Q1 | $1.8M | Buy |
|
|||||
|
2020
Q4 | $1.38M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $811K | Buy |
|